Long-Term Study of CN-801 - Open-label study in patients with excessive daytime sleepiness associated with idiopathic hypersomnia -
Latest Information Update: 04 Dec 2018
At a glance
- Drugs Modafinil (Primary)
- Indications Hypersomnia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Alfresa Pharma Corporation
- 02 Feb 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2016 New trial record